Statistics

Total Visits

Views
LONG-TERM (104-WEEK) EFFICACY AND SAFETY PROFILE OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE III, RANDOMIZED, CONTROLLED TRIAL AND OPEN-LABEL EXTENSION (PALACE 1)53

Select a period of time:

Number of views in the range

Views
LONG-TERM (104-WEEK) EFFICACY AND SAFETY PROFILE OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE III, RANDOMIZED, CONTROLLED TRIAL AND OPEN-LABEL EXTENSION (PALACE 1)10

Views

Views
June 20250
July 20256
August 20251
September 20251
October 20251
November 20251
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Turkey2
Brazil2
Argentina1
Colombia1
Ecuador1
Kenya1
United States1
Venezuela1
 

Top cities views

Views
Istanbul2
Fayetteville1
Indiara1
Latacunga1
Nairobi1
Sorocaba1
Viedma1
Yarumal1